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Abstract
Background: We recently demonstrated that feeding a natural CLAt10,c12-enriched butter to lean female rats resulted
in small, but significant increases in fasting glucose and insulin concentrations, and impaired insulin tolerance. Our goal
was to extend these findings by utilizing the diabetes-prone female fatty Zucker rat. Rats were fed custom diets
containing 45 % kcal of fat derived from control and CLAt10,c12-enriched butter for 8 weeks.
Methods: CLA t10,c12-enriched butter was prepared from milk collected from cows fed a high fermentable carbohydrate
diet to create subacute rumen acidosis (SARA); control (non-SARA) butter was collected from cows fed a low grain diet.
Female fatty Zucker rats (10 weeks old) were randomly assigned to one of four diet treatments: i) low fat (10 % kcal),
ii) 45 % kcal lard, iii) 45 % kcal SARA butter, or iv) 45 % kcal non-SARA butter. A low fat fed lean Zucker group was used
as a control group. After 8 weeks, i) glucose and insulin tolerance tests, ii) insulin signaling in muscle, adipose and liver,
and iii) metabolic caging measurements were performed.
Results: Glucose and insulin tolerance were significantly impaired in all fatty Zucker groups, but to the greatest extent in
the LARD and SARA conditions. Insulin signaling (AKT phosphorylation) was impaired in muscle, visceral (perigonadal)
adipose tissue and liver in fatty Zucker rats, but was generally similar across dietary groups. Physical activity, oxygen
consumption, food intake and weight gain were also similar amongst the various fatty Zucker groups.
Conclusions: Increasing the consumption of a food naturally enriched with CLAt10,c12 significantly worsens glucose and
insulin tolerance in a diabetes-prone rodent model. This outcome is not explained by changes in tissue insulin signaling,
physical activity, energy expenditure, food intake or body mass.
Keywords: Conjugated linoleic acid, CLA (t10,c12), Glucose tolerance, Insulin tolerance, Insulin-stimulated glucose uptake,
Female Zucker rats
Background
Conjugated linoleic acid (CLA) refers to the geometric and
positional isomers of linoleic acid (C18:2 n-6). The most
abundant naturally occurring CLA isomers are CLAc9,t11
(76 %) and CLAt10,c12 (1 %) [1, 2], and are derived from
food sources containing ruminant fat [3]. Early studies
demonstrated that supplementation of CLA in the diets of
mice caused massive losses of body fat, essentially creating
a lipoatrophic condition [4–6]. Indeed, such findings fueled
a subsequent interest in supplemental CLA as a potential
tool to combat obesity. However, the weight loss effects of
supplemental CLA in humans is much more modest
[7–10]. Furthermore, an unexpected outcome of the earlier
CLA studies was an increase in indices of insulin resistance,
which was evident in mice [4, 5] and overweight humans
[7–10], and generally attributed to the CLAt10,c12 isomer
[11]. Conversely, there is evidence that the CLAc9,t11
isomer may confer insulin sensitizing effects [12].
The majority of studies to date have examined the ef-
fects of supplemental CLA, as opposed to examining the
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outcome of consuming food naturally enriched with CLA.
More specifically, almost no studies have examined
the metabolic consequences of consuming a food source
in which the CLA isomer content has been naturally
altered i.e. not merely adding CLA isomer in the chemical
form to a food. To this end, we recently examined the
impact of feeding a CLAt10,c12-enriched butter (60 % of
total kcal) to lean, healthy female rats. Our findings indi-
cated that feeding the CLAt10,c12-enriched butter resulted
in small, but significant increases in fasting glucose and
insulin concentrations, as well as impaired insulin toler-
ance [13]. However, there was no effect of the enriched
butter on glucose or pyruvate tolerance, or on insulin-
stimulated glucose uptake in muscle [13]. Shortly after
our study was published, there was another report show-
ing that feeding butter enriched in the CLAc9,t11 isomer to
lean rats prevented the hyperinsulinemia induced by a
high fat diet; interestingly, there was also no effect on oral
glucose tolerance in this study [14]. Collectively, these two
studies demonstrate a potential, albeit relatively small,
effect of consuming natural food sources with altered
CLA isomer content on indices of insulin sensitivity.
Given the relatively small effect of CLAt10,c12-enriched
butter on indices of insulin resistance in lean, healthy
rats in our previous study [13], we decided to next
examine the impact of feeding this potentially “less
healthy” butter to fatty female Zucker rats, which de-
velop insulin resistance when placed on a high fat diet
[15]. We speculated that the general lack of negative
consequences to feeding SARA butter in our previous
study was due to the choice of lean rats as a model, and
that a rodent model with a predisposition towards dia-
betes would be more likely to show negative effects on
glucose and insulin tolerance, and insulin signaling. As
in our previous study [13], we fed dairy cows a high
grain, low forage diet to induce a condition known as
subacute rumenal acidosis (SARA), which is defined as a
decrease in rumenal pH below 5.6 for 4–6 hrs during a
24-h period [16, 17]. This decrease in pH results in a
significant increase in the production of the CLAt10,c12
isomer due to incomplete biohydrogenation of polyun-
saturated fatty acids [18].
Overall, our goal was to extend our previous findings by
investigating the impact of a CLA t10,c12-enriched butter
on glucose and insulin tolerance, as well as insulin signal-
ing in muscle (oxidative and glycolytic), adipose (subcuta-
neous and visceral) and liver tissues, in an obese, diabetes
prone rat model. To this end, female fatty Zucker rats
were fed custom diets containing high amounts of fat
(45 % of total kcal) derived from SARA and non-SARA
butter for 8 weeks. We hypothesized that, unlike lean in-
sulin sensitive rats, fatty Zucker rats would demonstrate a
clear worsening of both glucose and tolerance, as well as
impaired insulin signaling in muscle, adipose and liver.
Methods
Ethics statement
All procedures were carried out in accordance with the
recommendations of the Canadian Council of Animal
Care, and were approved by the Animal Care Committee
at the University of Guelph (Animal Utilization Protocols
09R046 and 1515). All surgeries on rodents were per-
formed under sodium pentobarbital anesthesia and all ef-
forts were made to prevent discomfort and suffering.
Feeding of cows, milk collection and processing
Procedures for feeding cows and collecting milk were the
same as reported in our previous study [13]. Six lactating
Holstein cows housed at the Ponsonby Dairy Research
Centre, University of Guelph, Guelph, Ontario were used
in this study. The cows were randomly assigned to one of
two dietary treatments for a total of 21 days. The two diets
were: i) a high-forage/low-grain diet (n = 4 cows) designed
to promote a stable and optimal rumenal pH, or ii) a
SARA-inducing high-grain diet containing readily fer-
mentable carbohydrates (n = 2 cows) intended to reduce
rumen pH resulting in a shift in the biohydrogenation
pathway leading to elevated levels of CLAt10,c12 in milk
fat. Milk collection took place on days 13 through 21.
Two to four cows provided sufficient milk to make the ne-
cessary quantities of butter to perform the current and
previous study [13]. The milk from each cow was col-
lected separately, placed on ice, and transferred to the
University of Guelph Food Technology Centre where it
was pooled by treatment and processed to make unsalted
butter; the fatty acid profiles were analyzed and previously
reported [19]. All animals were handled and cared for in
accordance with the Canadian Council on Animal Care
regulations, and as approved the Animal Care Committee
at the University of Guelph.
Experimental animal groups
Eight female lean Zucker rats and 36 female fatty Zucker
rats from Charles River (Quebec, Canada) were used in this
study. Rats were 10 weeks old upon arrival and were ran-
domly assigned 2–3 rats per cage in a room with a 12-h
light/dark cycle. Rats were allowed free access to water and
a low fat (10 % kcal) diet for a 1-week acclimatization
period. Subsequently, for an 8-week period, the lean Zucker
rats were fed the low fat diet and the fatty Zucker rats were
randomly assigned to one of four diet treatments: i) low fat
(10 % kcal, LF), ii) 45 % kcal lard (LARD) as a positive con-
trol i.e. one in which we expected to see the development
of glucose and insulin intolerance, iii) 45 % kcal SARA but-
ter (SARA), or iv) 45 % kcal non-SARA butter (non-SARA).
Animals were allowed ad libitum access to food and water.
Food intake (daily) and body mass (weekly) were monitored
regularly throughout the treatment period.
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Diet preparation
Two butter diets (non-SARA, SARA) were made in order
to evaluate the physiological responses (glucose and insu-
lin tolerance, insulin signaling) from consuming healthy
and potentially unhealthy butters. A purified low fat diet
(Research Diets D12450B, New Brunswick, New Jersey)
containing 10 % kcal from fat (5.5 % soybean oil and
4.5 % lard) and a purified high fat diet (Research Diets
D12451) containing 45 % kcal from fat (5.5 % soybean
oil and 39.5 % lard) were used for this study. A premix
(Research Diets D12451px) identical in composition to
the high fat diet, excluding the fat content, was used to
prepare the custom 45 % kcal non-SARA and SARA
butter diets. To make each custom butter diet, 1.61 kg
of each type of butter was mixed with 5.12 kg of pre-
mix. Diets were partitioned into small airtight con-
tainers and stored at −20 °C until use.
Glucose tolerance test
After a 6 h fast, blood glucose was measured from the
tail of each rat before receiving a bolus injection of glu-
cose (2 g/kg) into the intraperitoneal cavity. Blood glu-
cose concentrations were measured with glucose strips
and a glucometer (Freestyle Lite, Abbott Diabetes Care
Inc., Alameda, CA) at 15, 30, 45, 60, 90 and 120 min
post injection. Incremental area under the curve (AUC)
for the blood glucose response was calculated from the
baseline blood glucose concentration.
Insulin tolerance test
Insulin tolerance tests were performed 3 h after food was
removed from the rats’ cage. Blood glucose concentrations
were measured as described above. After measuring the
initial blood glucose concentration each rat was given an
intraperitoneal injection of insulin (Humulin) at a dosage
of 0.75 U/kg. Blood measurements were taken at 15, 30,
45 and 60 min post injection. Incremental area above the
curve (AAC) for the blood glucose response was calcu-
lated from the baseline blood glucose concentration.
Glucose and insulin tolerance tests were separated by
at least 2 days.
Metabolic caging measurements
During the last (8th) week, animals were housed indivi-
dually in a Comprehensive Lab Animal Monitoring
System (CLAMS, Columbus Instruments, Columbus,
OH) with free access to food and water for a 24 h light-
dark cycle similar to the previous 7 weeks. 24-h has been
used by others as a suitable period of time to assess meta-
bolic activity [20]. Measurements were taken during the
light (8 am to 8 pm) and dark (8 pm to 8 am) phases for
physical activity and oxygen uptake (VO2). The first 2 h of
measurements were discarded to allow for acclimation.
Insulin injection and tissue collection
Animals were fasted overnight for 6 h before being anes-
thetized with sodium pentobarbital (60 mg/kg body mass).
From the right side of the body, red gastrocnemius muscle
(RG, fast oxidative glycolytic), white gastrocnemius muscle
(WG, glycolytic), subcutaneous (SQAT, inguinal) and
visceral (VAT, perigonadal) adipose tissue samples were
obtained and flash frozen in liquid nitrogen and stored
at −80 °C for later analysis. Animals were then injected
with a maximal insulin dose (7.5 U/kg). 15 min later, tis-
sues from the left side of the animal (RG, WG, SQAT,
VAT), as well as the median lobe of the liver were ob-
tained to assess phosphorylation of AKT. Samples were
flash frozen in liquid nitrogen and stored at −80 °C until
subsequent analyses.
Western blotting
Muscle, adipose and liver samples were homogenized in
ice-cold lysis buffer for two 1-min cycles in the Fast
Prep® tissue homogenizer (MP Biomedicals, Quebec,
Canada) and then centrifuged at 1500 g for 15 min at
4 °C. The supernatant/infranatant was carefully re-
moved and the protein concentration was determined
using the BCA method; equal amounts of protein were
loaded into 15 well 10 % SDS-PAGE acrylamide gels
along side a colored protein ladder. The proteins were
separated using approximately 1.5 h of electrophoresis
at 100-130 mV and subsequently transferred onto a
nitrocellulose membrane for 2 h at 200 mA (4 °C) using
a Bio-Rad Mini-PROTEAN Tetra Cell system. Mem-
branes were incubated in Tris buffered saline–0.01 %
tween (TBST) supplemented with 5 % non-fat dry milk
for 1 h to block non-specific protein binding. The
membranes were incubated overnight at 4 °C in pri-
mary antibodies (p-AKT Thr308 and p-AKT Ser 473;
Cell Signaling, Massachusetts, USA; 1:1000 dilution in
TBST with 5 % BSA). Unbound primary antibody was
washed away with TBST prior to incubation for 1 h at
room temperature with HRP-conjugated goat anti-
rabbit secondary antibody (1:2000 in TBST-1 % non-fat
dry milk solution). Excess antibody was washed away
with TBST followed by TBS to clear the membrane for
imaging using ECL. Equal loading and transfer was de-
termined by detecting alpha-tubulin (Sigma Aldrich,
Missouri, USA).
Statistical analysis
Statistical analysis was conducted using Prism 6.0
(GraphPad Software Inc., 2008, San Diego, USA). Two-
way ANOVA was used when comparing two treatments
(insulin and diet), while differences between dietary
groups only were determined using a one-way ANOVA,
followed by a Fisher LSD posthoc test. Statistical signifi-
cance was accepted at p ≤ 0.05.
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Results
Fatty acid profile of the custom butter
The content of various conjugated linoleic isomers of
the non-SARA and SARA butters, as well as in the final
prepared diet is shown in Table 1. This is the identical
butter used in our previous study which has already
been reported [13]. However, the fat content of the final
prepared diet in the current study (45 % kcal) was lower
than that used in our previous study (60 % kcal); there-
fore, the content of the CLA isomers per 100 g of diet is
different than previously reported [13]. Briefly, all mea-
sured CLA isomers demonstrated some increase in the
SARA butter relative to the control butter, with the total
CLA content increasing by about 3-fold. In the prepared
diet, the most abundant CLA isomer, c9, t11, was in-
creased by ~2-fold (0.28 ± 0.03 vs. 0.12 ± 0.04 g/100 g diet;
p <0.05). The t10, c12 CLA isomer was increased the
most, by ~10-fold in the final prepared diet (0.024 ± 0.001
vs. 0.002 ± 0.0002 g/100 g diet; p <0.001).
Body mass and food intake
At the beginning of the trial, lean Zuckers weighed
197 ± 5 g, and the fatty Zucker rats weighed 377 ± 4 g.
After 8 weeks, the lean Zucker rats weighed 262 ± 10 g
and the fatty Zucker rats collectively weighed 585 ± 9 g.
There were no significant differences between the vari-
ous fatty Zucker groups (Table 2). Average daily food
intake (Table 2) during the 8 weeks was similar in all
fatty Zucker groups, and significantly greater than lean
Zuckers (20 ± 0.5 vs. 13.5 ± 0.3 g/d; p < 0.05).
Glucose and insulin tolerance tests
The calculated area under the curve (Fig. 1a) for glucose
tolerance was greatest (p <0.05) in the LARD and SARA
groups followed by the LF and non-SARA groups. AUC
for all fatty Zucker groups was significantly greater than
the lean Zucker group (p <0.05). The calculated area
above the curve (Fig. 1b) for the insulin tolerance test
showed essentially the same pattern as for the glucose
tolerance test. Area above the curve was smallest (indi-
cating poorest insulin response) in the LARD and SARA
groups (p <0.05), followed by the LF and non-SARA
groups (p <0.05). In fact, the LARD and SARA-butter
fed fatty Zucker rats showed essentially no drop in blood
glucose in response to insulin. All fatty Zucker groups
demonstrated an impaired insulin response relative to
the lean Zucker group (p <0.05).
Physical activity and oxygen uptake
Lean Zucker rats were significantly more active during
the dark (awake) phase than during the light phase
(Table 3); fatty Zucker rats generally had similar activity
levels during both the light and dark phases. During
both the light and dark phase, lean Zuckers were signifi-
cantly more active compared all fatty Zucker groups.
During the dark phase, SARA and non-SARA rats were
the least active groups (p <0.05). Only the lean Zucker
rats showed a significant increase in oxygen uptake in
the dark vs. the light phase. During both the light and
dark phases, lean Zucker rats had a significantly greater
oxygen uptake than the fatty Zucker groups (p <0.05).
Table 1 Content of linoleic acid (18:2 9c, 12c) and conjugated linoleic acid isomers in non-SARA (control) and SARA diets (g/100 g)
Fatty acid Non-SARA diet SARA diet
g/100 g of butter fatb g/100 g dieta g/100 g of butter fatb g/100 g dieta
18:2 9c, 12c 1.72 ± 0.03 0.41 ± 0.007 2.50 ± 0.225* 0.60 ± 0.05*
18:2 11t, 15c 0.07 ± 0.005 0.017 ± 0.001 0.39 ± 0.002* 0.09 ± 0.005*
18:2 9c, 11t 0.49 ± 0.15 0.12 ± 0.04 1.16 ± 0.144* 0.28 ± 0.03*
18:2 9t, 11c 0.01 ± 0.00 0.002 ± 0.001 0.08 ± 0.004* 0.02 ± 0.001*
18:2 10t, 12c 0.01 ± 0.001 0.002 ± 0.0002 0.10 ± 0.003* 0.024 ± 0.001*
18:2 9t, 11t and 10t, 12t 0.03 ± 0.004 0.007 ± 0.001 0.08 ± 0.004* 0.02 ± 0.001*
18:2 11t, 13t 0.01 ± 0.002 0.002 ± 0.0005 0.03 ± 0.004* 0.007 ± 0.001*
Total CLA 0.62 ± 0.05 0.15 ± 0.012 1.84 ± 0.16* 0.44 ± 0.04*
Data presented as mean plus/minus standard deviation, in g/100 g of butter fat or prepared diet (a45 % kcal from butter). The main CLA isomers, 9c, 11t and 10t,
12c are bolded *, significantly different from non-SARA butter (p < 0.05). n = 4 batches of non-SARA butter, and 2 batches of SARA butterb as previously
reported [13]
Table 2 Mean daily food intake and final body mass
Lean Zucker (LF diet) Fatty Zucker (LF diet) Fatty Zucker (Lard diet) Fatty Zucker (SARA diet) Fatty Zucker (non-SARA diet)
Food intake (g/day) 27.1 ± 0.6a 40.5 ± 0.7b 39.8 ± 0.8b 40.2 ± 0.8b 37.8 ± 1.4b
Final body mass (g) 262 ± 10a 546 ± 21b 588 ± 16b 593 ± 10b 606 ± 18b
Mean daily food intake over 8 weeks, and final body mass after 8 weeks. Data are presented as mean plus/minus standard error. n = 8−10 per group. Groups
which share a letter are not statistically different. Statistical significance accepted at p < 0.05. LF low fat
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Insulin signaling
Muscle
In both RG and WG, acute insulin injection significantly
increased phosphorylation of Ser and Thr residues; this
response was significantly blunted in fatty Zucker groups
regardless of diet (Fig. 2). In general, there were no sig-
nificant differences in AKT phosphorylation amongst
the different fatty Zucker groups.
Adipose tissue
In SQAT (Fig. 3), insulin administration significantly
increased p-Ser AKT in lean Zuckers, LF and SARA
fatty Zuckers, but not in the LARD and non-SARA groups
(p < 0.05). p-Thr AKT was increased in all groups, and
was the greatest in the lean Zuckers and the least in the
low-fat fed fatty Zuckers (p < 0.05). In VAT (Fig. 3), insulin
response was consistently impaired in the high fat fed fatty
Zucker rats. Insulin acutely increased p-Ser AKT in lean
and non-SARA Zuckers (p < 0.05), although the response
was significantly blunted in the non-SARA group. p-Thr
AKT increased in response to insulin only in the low-fat
fed lean and fatty Zuckers (p < 0.05), but not the Lard,
SARA or non-SARA groups.
Liver
Liver AKT content was only measured post insulin injec-
tion. p-Ser AKTand p-Thr AKT content after insulin injec-
tion was generally lower in the fatty Zucker rats (Fig. 4).
Discussion
In a recent study, we demonstrated that feeding a high fat
butter-based diet enriched in CLAt10,c12 to lean healthy ro-
dents caused significant, but small increases in fasting
blood glucose and insulin concentrations [13]. Insulin toler-
ance was significantly impaired by feeding the CLAt10,c12-
enriched butter, but we did not observe any significant
impairment in either glucose tolerance or insulin stim-
ulated muscle glucose uptake [13]. Altogether, these
findings demonstrated a minimal impact of consuming
large amounts of a food naturally enriched in the spe-
cific CLA isomer believed to cause insulin resistance.
Therefore, the purpose of the present study was to ex-
tend these initial findings by examining the metabolic
impact of feeding a CLAt10,c12-enriched butter to fe-
male fatty Zucker rats, which are known to develop in-





































































































Fig. 1 Calculated (a) area under the curve for glucose tolerance, and
(b) area above the curve for insulin tolerance tests. Data are
presented as mean plus standard error. n = 8−10 per group. Groups
which share a letter are not statistically different. Statistical
significance accepted at p < 0.05. LZ, lean Zuckers; FZ, fatty Zuckers;
LF, low fat; SARA, subacute rumen acidosis
Table 3 Physical activity and oxygen uptake
Lean Zucker (LF diet) Fatty Zuck (LF diet) Fatty Zucker (Lard diet) Fatty Zucker (SARA diet) Fatty Zucker (non-SARA diet)
Activity, beam
breaks
light 2902 ± 190a 1152 ± 189b 1274 ± 72b 855 ± 110b 951 ± 84b
dark 4730 ± 780*A 1827 ± 252B 1572 ± 182BC 854 ± 70C 975 ± 68C
VO2, mL/hour/kg light 21.6 ± 1.3
a 14.3 ± 0.9bc 15.6 ± 0.4b 13.0 ± 0.7c 12.9 ± 0.6c
dark 26.7 ± 1.5*A 16.2 ± 1.0B 16.4 ± 0.4B 13.3 ± 0.9C 13.1 ± 0.6C
Physical activity and oxygen uptake in Zucker rats fed various diets for 8 weeks. Data are presented as mean plus/minus standard error. n = 8-10 per group.
Lower case letters are used to compare groups in the light phase, upper case letter are used to compare groups in the dark phase, and an asterisk denotes a
significant difference between light and dark phases. Groups which share a letter are not statistically different. Statistical significance accepted at p < 0.05. LF low
fat; VO2 oxygen uptake; SARA subacute rumen acidosis
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[15]. To this end, we i) performed whole-body glucose
and insulin tolerance tests, and ii) examined acute insu-
lin signaling in response to a maximal insulin dose in
skeletal muscle (red and white gastrocnemius), adipose
tissue (subcutaneous and visceral depots), as well as
liver. Finally, we iii) assessed changes in metabolic rate
(oxygen uptake) and physical activity in a metabolic ca-
ging system.
Our current findings extend our previous observations
that feeding a butter naturally enriched in CLAt10,c12 has a
negative impact on whole body glucose homeostasis. How-
ever, unlike our previous study in which insulin, but not
glucose tolerance was impaired by the CLAt10,c12 enriched
butter [13], both glucose and insulin tolerance were im-
paired by the SARA (high CLAt10,c12) butter in the present





























































































































































































Fig. 2 Phosphorylated Thr and Ser AKT content in red (a, b) and white (c, d) gastrocnemius muscle before and after an acute insulin injection. Data
are presented as mean plus standard error. n = 8−10 per group. Groups which share a letter are not statistically different. * indicates a significant
difference between pre and post insulin conditions. Statistical significance accepted at p < 0.05. LZ, lean Zuckers; FZ, fatty Zuckers; LF, low fat; SARA,
subacute rumen acidosis
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was essentially identical to that induced by a diet contain-
ing similar amounts of lard. The negative impact of the di-
ets containing lard and SARA-butter was most apparent
with the insulin tolerance tests, as there was essentially no
decrease in blood glucose in response to an in vivo insulin
injection. In the current study, the amount of fat (butter,
lard) provided by the diet was reduced to a more realistic
content compared to our previous study (45 % kcal vs.
60 % kcal). Therefore, the reason for the more consistent
negative effect of CLAt10,c12-enriched butter in the present
study was almost certainly the choice of rodent model. We
utilized fatty female Zucker rats in this study as they de-
velop overt diabetes when placed on a moderately high fat
diet i.e. 45 % kcal from fat, and are a commonly used model
for human obesity. Thus, our primary hypothesis appears
to be correct in that a more obesity/diabetes prone animal
demonstrated a more consistent impairment in glucose
homeostasis (both glucose and insulin tolerance) compared
to the lean healthy rats used in our previous study in which
only insulin tolerance was impaired [13].
As an extension to our previous work, we also assessed
insulin signaling in two muscle fiber types (oxidative and
glycolytic), two adipose tissue depots (subcutaneous and
visceral), as well as the liver. In both muscle fiber types,
AKT phosphorylation was consistently impaired in re-







































































































































































































Fig. 3 Phosphorylated Thr and Ser AKT content in subcutaneous (a, b) and visceral (c, d) adipose tissue before and after an acute insulin injection.
Data are presented as mean plus standard error. n = 8−10 per group. Groups which share a letter are not statistically different. * indicates a significant
difference between pre and post insulin conditions. Statistical significance accepted at p < 0.05. LZ, lean Zuckers; FZ, fatty Zuckers; LF, low fat; SARA,
subacute rumen acidosis
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Zucker rats, regardless of their diet. Therefore, impaired
maximal insulin signaling in skeletal muscle could not ac-
count for the fact that the greatest degree of glucose and
insulin intolerance was observed in the LARD and SARA
groups. Certainly, it is possible that insulin sensitivity ra-
ther than maximal response was affected, and that our
choice of a maximal insulin dosage precluded our ability to
detect any differences between groups. However, as evident
in Figs. 2 and 3, the increase in AKT phosphorylation in
either muscle fiber was quite small in the fatty Zucker rats,
and in some cases, the increase in response to insulin was
not significant. Therefore, changes in AKT phosphoryl-
ation in the Zucker rats in response to a lower submaximal
concentration of insulin would likely have been undetect-
able. Interestingly, AKT phosphorylation in visceral adi-
pose tissue generally appeared to be most impaired in the
LARD and SARA groups. However, this was not true in
subcutaneous adipose tissue in which insulin signaling did
not appear to be as consistently or robustly inhibited.
Finally, AKT phosphorylation in liver was generally uni-
formly decreased amongst the various fatty Zucker groups,
with no differences between dietary groups. Overall, differ-
ences in maximally stimulated insulin signaling in any of
the main insulin-responsive tissues do not account for the
difference observed in our whole-body tolerance tests.
One of the limitations in our previous study was that
we did not include an assessment of physical activity or
oxygen consumption (metabolic rate). Therefore, in the
current study, animals were placed in a metabolic caging
unit to assess these parameters. As expected, all fatty
Zucker groups, regardless of diet, demonstrated a signifi-
cantly reduced oxygen uptake during both light and dark
phases. In fact, only the lean Zucker group showed a sig-
nificant increase in oxygen uptake during the dark (awake)
phase. Generally, there were few differences between
dietary treatments, although interestingly, both butter-fed
groups (SARA and non-SARA) had a lower oxygen uptake
than the LARD or low fat fed fatty Zuckers. Overall, phys-
ical activity tended to match the patterns in oxygen uptake
and was greatest in lean Zucker rats regardless of light or
dark phase. Physical activity was also the lowest in the
butter-fed groups. Although this decrease in physical ac-
tivity was not statistically significant, the percent decrease
in the butter-fed groups (~25-40 % decrease relative to
LARD), would explain the ~20 % decrease in oxygen up-
take in these groups. As seen in Table 2, there were no sig-
nificant differences in physical activity or oxygen uptake
between the SARA and non-SARA groups; therefore, the
impairment in glucose and insulin tolerance cannot be ex-
plained by changes in these parameters.
Collectively, our results from two studies ([13] and
present) suggest that the consumption of high amounts
of a food naturally enriched CLAt10,c12 increases the
risk of developing impaired glucose and insulin toler-
ance, although the degree of impairment is not as great
as that achieved in studies providing higher amounts of
purified CLAt10,c12 [11]. This may be due to several rea-
sons including i) a lower consumption of CLA in our
two studies (<0.5 g CLA/100 g diet) compared to pre-
vious rodent studies using supplemental CLA (>1 g/
100 g diet [4, 5]), ii) the fact that all CLA isomers, and
not just CLAt10,c12 were altered in the SARA butter, and
iii) a relatively shorter duration of feeding compared to




























































































Fig. 4 Phosphorylated Thr (a) and Ser (b) AKT content in liver after an
acute insulin injection. Data are presented as mean plus standard error.
n = 8−10 per group. Groups which share a letter are not statistically
different. Statistical significance accepted at p < 0.05. LZ, lean Zuckers;
FZ, fatty Zuckers; LF, low fat; SARA, subacute rumen acidosis
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studies have demonstrated that mixed isomer CLA sup-
plementation in obese Zucker rats can improve insulin
sensitivity and inflammation [21, 22], and recently, that a
CLAc9,t11 naturally enriched butter prevented high-fat diet
induced hyperinsulinemia in rats [14]. Therefore, since
the CLAt10,c12 isomer is the most greatly affected CLA
isomer in the SARA butter, demonstrating an ~10-fold
increase, it is reasonable to suggest it is this isomer that
is causing the impaired glucose and insulin tolerance.
However, we cannot rule out the possibility that, being
a naturally altered food, other constituents may have
been responsible as well.
Conclusion
The outcome of this study indicates that the consumption
of large amounts of a food naturally enriched in CLAt10,c12
content can significantly impair whole body glucose and
insulin tolerance in a diabetes-susceptible rodent model.
This outcome cannot be explained by changes in maximal
insulin response in major insulin responsive tissues
(skeletal muscle, liver, adipose tissue), or by changes in
physical activity or energy expenditure. Although we can-
not comment on whether the consumption of small of
amounts of CLAt10,c12-enriched foods might have similar
undesirable consequences, it may be prudent to examine
this possibility over longer periods of time in humans.
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